These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Protecting consumers from counterfeit drugs. FDA Consum; 2004 Oct; 38(3):12-3. PubMed ID: 15218838 [No Abstract] [Full Text] [Related]
43. [Standard preparations for drug control]. Stárkova D, Kadlecková M. Cesk Farm; 1991 Apr; 40(2):86-8. PubMed ID: 1893410 [No Abstract] [Full Text] [Related]
44. Information chapters in pharmacopoeias. Banes D. Ann Ist Super Sanita; 1975 Apr; 11(3-4):290-5. PubMed ID: 1234730 [Abstract] [Full Text] [Related]
45. [Considerations on the preparation and testing of Tablets]. Erbe S. Pharm Prax; 1966 Apr; 7():145-8. PubMed ID: 6001085 [No Abstract] [Full Text] [Related]
46. Microbiological quality of pharmaceutical preparations. Guidelines and methods. Bühlmann X, Gay M, Gubler HU, Hess H, Kabay A, Knüsel F, Sackman W, Schiller I, Urban S. Am J Pharm Sci Support Public Health; 1972 Apr; 144(6):165-86. PubMed ID: 4653122 [No Abstract] [Full Text] [Related]
47. [Microbiological in-process control in drug manufacture]. Seyfarth VH. Arzneimittelforschung; 1985 Apr; 35(1A):205-16. PubMed ID: 4039162 [Abstract] [Full Text] [Related]
49. Activities of the USP Analytical Microbiology Expert Committee during the 2000-2005 revision cycle. Sutton SV, Knapp JE, Porter D. PDA J Pharm Sci Technol; 2005 May; 59(3):157-76. PubMed ID: 16048116 [Abstract] [Full Text] [Related]
50. [Fifth supplement to the United States Pharmacopoeia XIX and National Formulary XIV]. Montanari L. Boll Chim Farm; 1979 Oct; 118(10):585-93. PubMed ID: 553525 [No Abstract] [Full Text] [Related]
51. [Analytical error in the acceptance criteria and testing of homogenous drugs by health authorities]. Vianello S. Boll Chim Farm; 1981 Jun; 120(6):313-29. PubMed ID: 7306394 [No Abstract] [Full Text] [Related]
53. Comparison of methods for detection of particulate matter in large-volume perenterals. Blanchard J, Thompson CM, Schwartz JA. Am J Hosp Pharm; 1976 Feb 07; 33(2):144-50. PubMed ID: 1258874 [Abstract] [Full Text] [Related]
54. [Control of quality of drugs in Poland]. Kubikovskii P. Farmatsiia; 1970 Feb 07; 19(1):13-7. PubMed ID: 5441451 [No Abstract] [Full Text] [Related]
55. WHO expert committee on specifications for pharmaceutical preparations. Twenty-fifth report. World Health Organ Tech Rep Ser; 1975 Feb 07; (567):1-115. PubMed ID: 807046 [No Abstract] [Full Text] [Related]
56. [Microbiological quality of pharmaceutical products not mandatorily sterilized]. Tagliapietra L. Boll Chim Farm; 1978 Jan 07; 117(1):1-13. PubMed ID: 743347 [No Abstract] [Full Text] [Related]
57. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organization. World Health Organ Tech Rep Ser; 2005 Jan 07; 929():1-142, backcover. PubMed ID: 16353684 [Abstract] [Full Text] [Related]
58. Drug product quality. Exp Med Surg; 1971 Jan 07; 29(1):135-44. PubMed ID: 5147595 [No Abstract] [Full Text] [Related]
59. Evaluation and testing of drugs for mutagenicity: principles and problems. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser; 1971 Jan 07; 482():1-18. PubMed ID: 5003605 [No Abstract] [Full Text] [Related]
60. [L-lysine ethylester as a substrate for trypsin assay in Czechoslovak Pharmakopeia]. Bárta Z, Kimlová I, Libický A. Cesk Farm; 1968 Jan 07; 17(1):7-11. PubMed ID: 5668241 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]